Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
148408-66-6
|
| gptkbp:developedBy |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:drugClass |
selective estrogen receptor modulator
antiestrogen |
| gptkbp:hasInChIKey |
gptkb:QJQJQJQJQJQJQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C22H23N3O2
|
| gptkbp:hasSMILES |
CN(C)CCOC1=CC=C(C=C1)NC(=O)C=CC2=CC=CC=C2
|
| gptkbp:hasTherapeuticUse |
investigational drug for breast cancer
|
| https://www.w3.org/2000/01/rdf-schema#label |
BMS-181176
|
| gptkbp:IUPACName |
(E)-N-(4-(2-(dimethylamino)ethoxy)phenyl)-3-phenylacrylamide
|
| gptkbp:PubChem_CID |
CHEMBL2105932
9831572 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
not approved for medical use
|
| gptkbp:synonym |
(E)-N-(4-(2-(dimethylamino)ethoxy)phenyl)-3-phenylacrylamide
BMS 181176 BMS181176 |
| gptkbp:bfsParent |
gptkb:Bk-247
|
| gptkbp:bfsLayer |
7
|